▷ Cotización de KALV Noticias y Datos Financieros de KalVista Pharmaceuticals Inc

ESCÁNER DE ACCIONES AMERICANAS DE TRADINGCERO.COM (VERSIÓN 1.0) Hora Nueva York:
(2022-07-04)Formato Y-M-D

EARNINGS AYER: Ayer no hubo informes de resultados.
EARNINGS HOY: No hay informes de resultados previstos para hoy.
EARNINGS MAÑANA: No hay informes de resultados previstos para mañana.

IPOS AYER: Ayer no hubo IPOS.
IPOS HOY: No hay IPOS previstas para hoy.
IPOS MAÑANA: No hay IPOS previstas para mañana.

[ Escáners ]  1. Escáner de TODAS las Acciones.
  2. Escáner de PennyStocks (<= $10).
  3. Escáner de SmallCaps ($10 < y <= $80).
  4. Escáner de LargeCaps ( > $80).

[ Screener ]  >> Screener de TradingCero.com

[ Calendario de Earnings ]  >> Empresas que publicarán sus Informes de Resultados próximamente

[ Calendario de IPOS ]  >> Empresas que debutarán en WallStreet próximamente

[ Industrias / Sectores ]  >> Listado de Insdustrias y Sectores en WallStreet

[ Panel Predictivo ]  >> Acceso restringido

[ Descarga de Informes ]  >> Acceso restringido

[ Registro de Cambios ]  >> Registro de Cambios en el Escáner.

[ PÁGINA ACTUALIZADA EL 2022-07-04 23:20:14 hrs (New York) ]

Nombre:Nombre de la Empresa, Número de Empleados y web si está disponible	KalVista Pharmaceuticals Inc Empleados: 56 Web Disponible
Industria:Industria a la que pertenece la Empresa	Pharmaceutical Preparation Manufacturing
Sector:Sector al que pertenece la Empresa	Manufacturing
Market Cap.:Capitalización de Mercado de la Empresa	242.26 M
Insider Own:Porcentaje de Acciones que poseen los Socios de la Empresa	0.7 %
Shares:Número total de Acciones de la Empresa	24.48 M
Float:Flotante (Acciones disponibles para comprar/vender) de la Empresa	23.85 M
Short Float:Porcentaje de Acciones en Corto de los Inversores sobre la Empresa	5.68 %
Volumen:Volumen de operaciones de la última sesión de mercado sobre la Empresa	0.1 M
Vol. Medio:Volumen Medio Diario de operaciones realizadas en el Mercado sobre la Empresa	0.34027 M
Último %:Cambio en porcentaje: Diario, Semanal, Mensual y Anual de la Empresa	0.6 % Semanal %: -5.02 % Mensual %: 10.69 % Anual %: 1 %

TODAS LAS NOTICIAS DE [ KALV ]

FECHA / HORA		ÚLTIMAS NOTICIAS
2022-06-23 06:45:00		>> KalVista Pharmaceuticals to Present Data at the 2022 Meeting of the European Academy of Allergy and Clinical Immunology EAACI ...KalVista Pharmaceuticals to Present Data at the 2022 Meeting of the European Academy of Allergy and Clinical Immunology EAACI
2022-06-08 06:55:00		>> KalVista Pharmaceuticals Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program ...KalVista Pharmaceuticals Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program
2022-06-03 08:10:00		>> Will KalVista Pharmaceuticals NASDAQ KALV Spend Its Cash Wisely ...Will KalVista Pharmaceuticals NASDAQ KALV Spend Its Cash Wisely
2022-06-03 07:00:00		>> KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4 ...KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4
2022-06-01 06:45:00		>> KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference ...KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference
2022-05-27 06:45:00		>> KalVista Pharmaceuticals Announces Changes to Board of Directors ...KalVista Pharmaceuticals Announces Changes to Board of Directors
2022-05-17 06:45:00		>> KalVista Pharmaceuticals Announces Non Proprietary Name Selection for KVD900 ...KalVista Pharmaceuticals Announces Non Proprietary Name Selection for KVD900
2022-04-11 07:00:00		>> KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference ...KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference
2022-04-04 16:15:00		>> KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4 ...KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4
2022-03-22 07:00:00		>> KalVista Announces Publication of Additional KVD900 Data in Clinical amp Experimental Allergy ...KalVista Announces Publication of Additional KVD900 Data in Clinical amp Experimental Allergy
2022-03-10 07:00:00		>> KalVista Pharmaceuticals Reports Third Fiscal Quarter Results ...KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
2022-03-07 06:30:00		>> KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial ...KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial
2022-03-03 16:15:00		>> KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4 ...KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4
2022-02-28 16:15:00		>> KalVista Pharmaceuticals Presents Data Showing Rapid Reduction of Plasma Kallikrein Activity After Oral KVD900 Treatment and Early Symptom Relief From ...KalVista Pharmaceuticals Presents Data Showing Rapid Reduction of Plasma Kallikrein Activity After Oral KVD900 Treatment and Early Symptom Relief From HAE Attacks in Patients
2022-02-07 17:38:00		>> Monashee Investment Management LLC Buys Vanguard Total Stock Market ETF Hyperfine Inc Agree ...Monashee Investment Management LLC Buys Vanguard Total Stock Market ETF Hyperfine Inc Agree
2022-02-03 07:30:00		>> KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference ...KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
2022-02-02 07:30:00		>> KalVista Pharmaceuticals to Present Data on Oral On Demand HAE Therapy KVD900 at AAAAI 2022 ...KalVista Pharmaceuticals to Present Data on Oral On Demand HAE Therapy KVD900 at AAAAI 2022
2022-02-02 07:00:00		>> KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4 ...KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 c 4
2022-01-12 11:37:00		>> Hedge Funds Are Buying KalVista Pharmaceuticals Inc KALV ...Hedge Funds Are Buying KalVista Pharmaceuticals Inc KALV
2022-01-07 16:56:00		>> Center Coast Brookfield MLP amp Energy Infrastructure Fund Announces Board Update ...Center Coast Brookfield MLP amp Energy Infrastructure Fund Announces Board Update

TODOS LOS TWEETS [ KALV ]

HORA	USUARIO	TWEET
2022-07-01 07:42:23	TICKERON	kalv in uptrend rsi indicator exits oversold zone view odds for this and other indicators ...kalv in uptrend rsi indicator exits oversold zone view odds for this and other indicators
2022-06-29 09:53:31	HENRY	kalv dont miss stock market the biggest moves after a few hours ...kalv dont miss stock market the biggest moves after a few hours
2022-06-29 09:12:49	TICKERON	kalv enters an uptrend as momentum indicator exceeded the 0 level on june 17 2022 view odds for this and other i ...kalv enters an uptrend as momentum indicator exceeded the 0 level on june 17 2022 view odds for this and other i
2022-06-21 13:52:19	LUKIITASP	kalv nasdaq stock rating changed to hold kalvista pharmaceuticals incticker is 2971 off the historical suppo ...kalv nasdaq stock rating changed to hold kalvista pharmaceuticals incticker is 2971 off the historical suppo
2022-06-15 11:59:13	SEEKING ALPHA	kalv kalvista pharmaceuticals kalv investor presentation slideshow ...kalv kalvista pharmaceuticals kalv investor presentation slideshow
2022-06-14 11:01:33	MONICA	kalv nasdaq stock rating changed to strong buy kalvista pharmaceuticals incticker is 272 off the historical ...kalv nasdaq stock rating changed to strong buy kalvista pharmaceuticals incticker is 272 off the historical
2022-06-08 07:55:59	MONSTER2000	kalv nasdaq stock rating changed to sell kalvista pharmaceuticals inc ...kalv nasdaq stock rating changed to sell kalvista pharmaceuticals inc
2022-06-08 06:55:28	YELPFUL STOCK ALERTS	kalv kalvista pharmaceuticals presents promising preclinical data for oral factor xiia inhibitor programstock news alerts in bio ...kalv kalvista pharmaceuticals presents promising preclinical data for oral factor xiia inhibitor programstock news alerts in bio
2022-06-06 09:18:10	LUKIITASP	kalv nasdaq stock rating changed to sell kalvista pharmaceuticals inc ...kalv nasdaq stock rating changed to sell kalvista pharmaceuticals inc
2022-06-03 10:53:54	TICKERON	kalv in 225 downtrend declining for three consecutive days on june 2 2022 view odds for this and other indic ...kalv in 225 downtrend declining for three consecutive days on june 2 2022 view odds for this and other indic
2022-06-03 07:00:27	YELPFUL STOCK ALERTS	kalv kalvista pharmaceuticals reports inducement grants under nasdaq listing rule 5635c4stock news alerts in bio ...kalv kalvista pharmaceuticals reports inducement grants under nasdaq listing rule 5635c4stock news alerts in bio
2022-06-01 11:46:58	TICKERON	kalv in 789 downtrend sliding for three consecutive days on may 25 2022 view odds for this and other indicat ...kalv in 789 downtrend sliding for three consecutive days on may 25 2022 view odds for this and other indicat
2022-06-01 06:45:28	YELPFUL STOCK ALERTS	kalv kalvista pharmaceuticals to present at 13th annual jefferies healthcare conferencestock news alerts in bio ...kalv kalvista pharmaceuticals to present at 13th annual jefferies healthcare conferencestock news alerts in bio
2022-05-31 07:20:52	SHOGUNTRADE	kalv awaiting buy signal ...kalv awaiting buy signal
2022-05-27 06:45:27	YELPFUL STOCK ALERTS	kalv kalvista pharmaceuticals announces changes to board of directorsstock news alerts in bio ...kalv kalvista pharmaceuticals announces changes to board of directorsstock news alerts in bio
2022-05-26 11:59:08	SHORTALGO	kalv stock trading ideas awaiting buy signal learn more at ...kalv stock trading ideas awaiting buy signal learn more at
2022-05-24 10:34:04	CHARTMILL	the quick ratio of kalv is much better than the industry average of 732 ...the quick ratio of kalv is much better than the industry average of 732
2022-05-18 07:41:34	LUKIITASP	kalv nasdaq stock rating changed to buy kalvista pharmaceuticals inc ...kalv nasdaq stock rating changed to buy kalvista pharmaceuticals inc
2022-05-13 13:26:28	MEDIA SENTIMENT®	kalv new alert at ...kalv new alert at
2022-05-13 13:26:24	MEDIA SENTIMENT®	kalv new alert at ...kalv new alert at
2022-05-03 15:39:05	OPTION WAVES	kalv 2500 dec 16 2022 call underlying 1312 difference 4752daily volume 139475volume 1594oi ...kalv 2500 dec 16 2022 call underlying 1312 difference 4752daily volume 139475volume 1594oi
2022-05-03 15:15:09	OPTION WAVES	kalv 2250 dec 16 2022 call underlying 1317 difference 4147daily volume 130000volume 520oi ...kalv 2250 dec 16 2022 call underlying 1317 difference 4147daily volume 130000volume 520oi
2022-04-21 13:43:51	MICHAł ORZECHOWSKI	kalv ...kalv
2022-04-21 13:41:12	MICHAł ORZECHOWSKI	kalv ...kalv
2022-04-21 06:41:05	CHARTMILL	kalv was analyzed by 13 analysts the buy consensus is at 86 so analysts seem to be very confident about kalv ...kalv was analyzed by 13 analysts the buy consensus is at 86 so analysts seem to be very confident about kalv
2022-03-31 07:47:55	BENITOAE AMES	kalv for a limited time we are opening our trading chatroom to the public ...kalv for a limited time we are opening our trading chatroom to the public
2022-03-24 07:18:58	MAITE MERENDA	kalv awaiting short signal day trading by ultraalgo ...kalv awaiting short signal day trading by ultraalgo

[ [ Advertencia de riesgo ] ]

Por favor, recuerda que el Trading es una actividad que pone en riesgo tu dinero y antes de hacerlo debes entender y aceptar los riesgos que eso supone. TradingCero.com no ofrece recomendaciones sobre Inversión ni sobre compra o venta de acciones ni de ningún activo financiero.

TradingCero.com es una web que ofrece información sobre los mercados financieros y Criptodivisas - información de la que no nos responsabilizamos si tuviera algún error - además de publicar cursos de Trading que nos parezcan de calidad e interesantes para nuestros lectores. TODA la información que compartimos así como las sesiones de TRADING que hacemos en nuestro CANAL DE YOUTUBE es SÓLO con FINES EDUCATIVOS.

Es posible que la información mostrada en la Web de TradingCero.com y en el Escáner de Acciones Americanas contenga errores de los que no nos responsabilizamos. Usamos fuentes de información de distintos proveedores por lo que no nos podemos hacer responsables de los errores contenidos en dicha información. Si ves algún error en esta web o en los datos que muestra, por favor, escríbemos un email a pablo@tradingcero.com y lo corregiremos lo antes posible.

TradingCero.com forma parte del programa de afiliados de la Escuela de Trading Tradenet.com y como tal, no nos podemos responsabilizar de los errores o problemas incluídos en sus paquetes formativos y/o servicios profesionales que ofrezca como Escuela de Trading.

Puedes consultar nuestro aviso legal, política de privacidad y política de cookies cuándo lo desees !